Tenon Medical, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
November 14, 2023 at 09:34 pm
Share
Tenon Medical, Inc. reported earnings results for the third quarter and nine months ended September 30, 2023. For the third quarter, the company reported sales was USD 0.944 million compared to USD 0.208 million a year ago. Net loss was USD 3.33 million compared to USD 3.17 million a year ago. Basic loss per share from continuing operations was USD 1.46 compared to USD 2.82 a year ago.
For the nine months, sales was USD 2.12 million compared to USD 0.414 million a year ago. Net loss was USD 12.45 million compared to USD 11.01 million a year ago. Basic loss per share from continuing operations was USD 7.91 compared to USD 15.91 a year ago.
Tenon Medical, Inc. is a medical device company. The Company has developed the Catamaran SI Joint Fusion System that offers a novel, less invasive approach to the SI joint using a single, robust titanium implant. The system features the Catamaran Fixation Device which passes through both the axial and sagittal planes of the ilium and sacrum, stabilizing and transfixing the SI Joint along its longitudinal axis. The angle and trajectory of the Catamaran surgical approach is also designed to provide a pathway away from critical neural and vascular structures and into the strongest cortical bone. The Catamaran System is designed specially to resist vertical shear and rotation of the joint in which it was implanted, helping stabilize the joint in preparation for eventual fusion. The Company has also developed a proprietary two-dimensional (2D) placement protocol as well as a protocol for three-dimensional (3D) navigation utilizing the latest techniques in spine surgery.